Everything PR News

Medicines, Vaccines and Pharmaceuticals (MVP) Issues Communications RFP

Medicines, Vaccines and Pharmaceuticals (MVP) Issues Communications RFP

Purpose:

The goal of a proposed AWaRe campaign is to encourage governments to adopt the AWaRe categories by integrating them into their national essential medicines lists. If achieved, this could represent a tangible progressive step for countries in their efforts to reduce antimicrobial resistance and optimise antibiotic treatment. The tactical approach of the campaign is to target principally government decision- and policy-makers through traditional advocacy (advocacy forums, direct communications, opinion pieces in influential media, high-profile supporters) for a period of two years, and through a 4-week social media campaign and a global media launch, both of which will be curtain raisers for the overall effort.

Background:

The Access to Medicines, Vaccines and Pharmaceuticals (MVP) cluster works with countries and other partners to improve access to essential medicines and other health technologies of assured quality. The cluster collaborates with a wide range of international partners and expert networks, UN organizations and WHO Collaborating Centres and focuses on two broad areas of work: (1) the Regulation of medicines and other health technologies (medicines, vaccines, other biologicals, blood products, medical devices, and diagnostics); and (2) Innovation, Access and Use of medicines and other health products.

The AWaRe campaign One of the WHO’s flagship priorities is the global reduction of antimicrobial resistance. MVP has done extensive work on this issue and in 2017 developed the AWaRe strategy to assist countries address antimicrobial resistance nationally. The AWaRe strategy categorises antibiotics into three groups – ACCESS, WATCH and RESERVE – to facilitate the choice of treatment for common and serious infections in a way aimed at preserving their efficacy, thereby reducing the risk of resistance. AWaRe is part of the 2017 WHO Essential Medicines List. This means that it contains the antibiotics all health systems must have at the ready for their populations. In that sense, AWaRe is also a policy support to enable full access to antibiotic treatment for countries that face shortages and other access barriers.

Scope of Work:

Goal: To raise awareness of AWaRe as a useful tool to address AMR, and to advocate its adoption and implementation in countries. Possible indicators: 100 countries to have adjusted their essential medicines lists by integrating AWaRe 12 months from the beginning of the campaign; most countries 24 months after campaign launch. Audiences

Political leaders, policy-makers worldwide and influential networks, with particular attention to middle-income governments – we need to secure their political will to support and promote AWaRe in their countries

Health and agriculture ministries – we need to foster greater dialogue and cooperation between these two entities to work together on AMR

FAO and OIE (and possibly WTO) – we need to secure their collaboration Approach

Purpose of the work: To raise awareness of AWaRe as a useful tool to address AMR, and to advocate its adoption and implementation in countries. Possible indicators: 100 countries to have adjusted their essential medicines lists by integrating AWaRe 12 months from the beginning of the campaign; most countries 24 months after campaign launch.

Audiences:

Political leaders, policy-makers worldwide and influential networks, with particular attention to middle-income governments – we need to secure their political will to support and promote AWaRe in their countries

Health and agriculture ministries – we need to foster greater dialogue and cooperation between these two entities to work together on AMR

FAO and OIE (and possibly WTO) – we need to secure their collaboration Approach

Work to be performed: In collaboration with the Senior Communication Manager, MVP, the service provider will support the second aspect of the campaign (number 2 above), and help organise the global media launch of AWaRe. More specifically, and with substantial input from MVP, they will:

Due Date:

April 27th

Address:

vogela@who.int

Strong healthcare PR firms include Zeno Group and Edelman PR.

Exit mobile version